These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33433781)

  • 1. Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease.
    Simorgh S; Alizadeh R; Shabani R; Karimzadeh F; Seidkhani E; Majidpoor J; Moradi F; Kasbiyan H
    Neurotox Res; 2021 Jun; 39(3):598-608. PubMed ID: 33433781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Targeting of Human Olfactory Mucosa Stem Cells Following Intranasal Administration: a Novel Approach to Parkinson's Disease Treatment.
    Simorgh S; Bagher Z; Farhadi M; Kamrava SK; Boroujeni ME; Namjoo Z; Hour FQ; Moradi S; Alizadeh R
    Mol Neurobiol; 2021 Aug; 58(8):3835-3847. PubMed ID: 33860441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory mucosa stem cells: An available candidate for the treatment of the Parkinson's disease.
    Simorgh S; Alizadeh R; Eftekharzadeh M; Haramshahi SMA; Milan PB; Doshmanziari M; Ramezanpour F; Gholipourmalekabadi M; Seifi M; Moradi F
    J Cell Physiol; 2019 Dec; 234(12):23763-23773. PubMed ID: 31173364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of human olfactory system-derived stem cells into dopaminergic neuron-like cells: A comparison between olfactory bulb and mucosa as two sources of stem cells.
    Alizadeh R; Ramezanpour F; Mohammadi A; Eftekharzadeh M; Simorgh S; Kazemiha M; Moradi F
    J Cell Biochem; 2019 Dec; 120(12):19712-19720. PubMed ID: 31297865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs.
    Alizadeh R; Bagher Z; Kamrava SK; Falah M; Ghasemi Hamidabadi H; Eskandarian Boroujeni M; Mohammadi F; Khodaverdi S; Zare-Sadeghi A; Olya A; Komeili A
    J Chem Neuroanat; 2019 Mar; 96():126-133. PubMed ID: 30639339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of human olfactory ecto-mesenchymal stem cells restores locomotion in a rat model of Parkinson's disease.
    Farhadi M; Boroujeni ME; Kamrava SK; Bagher Z; Tehrani AM; Aghajanpour F; Ezi S; Soltani R; Khatmi A; Alizadeh R
    J Chem Neuroanat; 2021 Jul; 114():101961. PubMed ID: 33933574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantation of pure cultured olfactory ensheathing cells in an animal model of parkinsonism.
    Dewar D; Bentley D; Barnett SC
    Acta Neurochir (Wien); 2007; 149(4):407-14. PubMed ID: 17380250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Transcriptome to Behavior: Intranasal Injection of Late Passage Human Olfactory Stem Cells Displays Potential in a Rat Model of Parkinson's Disease.
    Alizadeh R; Boroujeni ME; Kamrava SK; Tehrani AM; Bagher Z; Heidari F; Bluyssen HAR; Farhadi M
    ACS Chem Neurosci; 2021 Jun; 12(12):2209-2217. PubMed ID: 34048212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
    Alizadeh R; Kamrava SK; Bagher Z; Farhadi M; Falah M; Moradi F; Boroujeni ME; Soleimani M; Kamyab A; Komeili A
    Neurosci Lett; 2019 Mar; 696():52-59. PubMed ID: 30552942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
    Danielyan L; Schäfer R; von Ameln-Mayerhofer A; Bernhard F; Verleysdonk S; Buadze M; Lourhmati A; Klopfer T; Schaumann F; Schmid B; Koehle C; Proksch B; Weissert R; Reichardt HM; van den Brandt J; Buniatian GH; Schwab M; Gleiter CH; Frey WH
    Rejuvenation Res; 2011 Feb; 14(1):3-16. PubMed ID: 21291297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
    Prediger RD; Batista LC; Medeiros R; Pandolfo P; Florio JC; Takahashi RN
    Exp Neurol; 2006 Dec; 202(2):391-403. PubMed ID: 16908021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.
    Danielyan L; Beer-Hammer S; Stolzing A; Schäfer R; Siegel G; Fabian C; Kahle P; Biedermann T; Lourhmati A; Buadze M; Novakovic A; Proksch B; Gleiter CH; Frey WH; Schwab M
    Cell Transplant; 2014; 23 Suppl 1():S123-39. PubMed ID: 25302802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolating nasal olfactory stem cells from rodents or humans.
    Girard SD; Devéze A; Nivet E; Gepner B; Roman FS; Féron F
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21876529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
    Gu S; Huang H; Bi J; Yao Y; Wen T
    Brain Res; 2009 Feb; 1257():1-9. PubMed ID: 19111525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
    Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
    J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal Administration of Extracellular Vesicles Derived from Human Teeth Stem Cells Improves Motor Symptoms and Normalizes Tyrosine Hydroxylase Expression in the Substantia Nigra and Striatum of the 6-Hydroxydopamine-Treated Rats.
    Narbute K; Piļipenko V; Pupure J; Dzirkale Z; Jonavičė U; Tunaitis V; Kriaučiūnaitė K; Jarmalavičiūtė A; Jansone B; Kluša V; Pivoriūnas A
    Stem Cells Transl Med; 2019 May; 8(5):490-499. PubMed ID: 30706999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
    Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
    Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The isolation of neural stem cells from the olfactory bulb of Parkinson's disease model.
    Hayakawa H; Hayashita-Kinoh H; Nihira T; Seki T; Mizuno Y; Mochizuki H
    Neurosci Res; 2007 Mar; 57(3):393-8. PubMed ID: 17222932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of neural stem cells from human olfactory mucosa into dopaminergic neuron-like cells.
    Ertem T; Uysal O
    IUBMB Life; 2024 Sep; 76(9):697-711. PubMed ID: 38662920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human olfactory bulb neural stem cells mitigate movement disorders in a rat model of Parkinson's disease.
    Marei HE; Lashen S; Farag A; Althani A; Afifi N; A AE; Rezk S; Pallini R; Casalbore P; Cenciarelli C
    J Cell Physiol; 2015 Jul; 230(7):1614-29. PubMed ID: 25536543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.